In recent years, GLP-1 medications such as Ozempic, Wegovy and Zepbound have ballooned in popularity. While GLP-1s have, for years, been a prescribed treatment for type 2 diabetes, they now are an FDA ...
MedPage Today on MSN
Adverse Event Risks Vary Among Asthma Biologics, FDA Data Show
CHICAGO -- Adverse event risks varied across biologics used by asthma patients, an analysis of data submitted to the FDA ...
Larimar Therapeutics Inc. (NASDAQ: LRMR) is trading lower on Monday after the company released data from the ongoing long-term open-label (OL) study evaluating daily subcutaneous 25 mg and 50 mg ...
Initial $100 million term loan to propel market share growth in the U.S. SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical ...
SAN ANTONIO -- Remimazolam (Byfavo) is poised to open a new frontier in anesthesiology, but caution is warranted to ensure off-label use does not devolve into the Wild West. Growing interest in the ...
Mohamed El-Erian, the former Pimco chief executive, called it a solid report suggesting "U.S. economic resilience going into an uncertain period"—and one that closed off the prospect of a Federal ...
Tired of vaccine misinformation? Here's a calm, practical guide to protect kids—what to ask your clinician, how to weigh the ...
Disney has designated the laboratory results as confidential — a move being contested by the attorney of the late doctor's ...
Court records show Disney has designated the laboratory results as confidential — a move that's being contested by the ...
The Department of Veterans Affairs spends billions on dubious and even fraudulent disabilities benefits. Meanwhile, some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results